- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 114-128 of
894 results
... William J Jusko, PhD Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22 ...
Document
IPR2024-00009, No. 2025 Exhibit - EX2025 Excerpt of Opening Expert Report of William J Jusko, PhD Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22
|
|
Cite Document
... of Dr Paul Dalby Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22 ...
Document
IPR2024-00009, No. 2026 Exhibit - EX2026 Excerpt of Opening Expert Report of Dr Paul Dalby Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22 MD 0303
|
|
Cite Document
... of Dr John Bantle Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22 ...
Document
IPR2024-00009, No. 2024 Exhibit - EX2024 Excerpt of Opening Expert Report of Dr John Bantle Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22 MD 030
|
|
Cite Document
1099 Exhibit: Proposed Stipulation
Document
IPR2024-00009, No. 1099 Exhibit - Proposed Stipulation (P.T.A.B. Mar. 29, 2024)
|
|
Cite Document
2110 Exhibit: EX2110 Verges, B and Charbonnel, B, After the LEADER trial and SU...
Document
IPR2023-00724, No. 2110 Exhibit - EX2110 Verges, B and Charbonnel, B, After the LEADER trial and SUSTAIN 6, how do we explain the cardiovascular benefits of some GLP 1 receptor agonis...
|
|
Cite Document
2535 Exhibit: EX2535 Declaration of Jenny C Wu
Document
IPR2023-00724, No. 2535 Exhibit - EX2535 Declaration of Jenny C Wu (P.T.A.B. Apr. 10, 2024)
|
|
Cite Document
3001 Exhibit: Exhibit 3001
Document
IPR2024-00009, No. 3001 Exhibit - Exhibit 3001 (P.T.A.B. Feb. 13, 2024)
|
|
Cite Document
2533 Exhibit: EX2533 Declaration of Jenny C Wu
Document
IPR2023-00724, No. 2533 Exhibit - EX2533 Declaration of Jenny C Wu (P.T.A.B. Mar. 6, 2024)
|
|
Cite Document
2534 Exhibit: EX2534 Declaration of Philip S May
Document
IPR2023-00724, No. 2534 Exhibit - EX2534 Declaration of Philip S May (P.T.A.B. Mar. 6, 2024)
|
|
Cite Document
2023 Exhibit: EX2023 Notice of Service for Defendants’ Supplemental Invalidity Co...
Document
IPR2024-00009, No. 2023 Exhibit - EX2023 Notice of Service for Defendants’ Supplemental Invalidity Contentions, In re Ozempic Semaglutide Patent Litigation, No 22 MD 03038 CFC D Del Nov...
|
|
Cite Document
2020 Exhibit: EX2020 Novo Nordisk Production Letter, In re Ozempic Semaglutide ...
Document
IPR2024-00009, No. 2020 Exhibit - EX2020 Novo Nordisk Production Letter, In re Ozempic Semaglutide Patent Litigation, No 22 MD 03038 CFC D Del Oct 17, 2023 REDACTED (P.T.A.B. Jan. 26...
|
|
Cite Document
2001 Exhibit: EX2001 Excerpt of Defendants’ Initial Invalidity Contentions Regarding US Patent Nos 8,129,343 8,536,122 8,1...
Document
IPR2024-00009, No. 2001 Exhibit - EX2001 Excerpt of Defendants’ Initial Invalidity Contentions Regarding US Patent Nos 8,129,343 8,536,122 8,114,833 8,920,383 9,775,953 9,457,154 and 10,335,462, In
|
|
Cite Document
2018 Exhibit: EX2018 Excerpt of Defendants’ Supplemental Invalidity Contentions Regarding US Patent Nos 8,129,343 8,536,122 8,114,833 8...
Document
IPR2024-00009, No. 2018 Exhibit - EX2018 Excerpt of Defendants’ Supplemental Invalidity Contentions Regarding US Patent Nos 8,129,343 8,536,122 8,114,833 8,920,383 9,775,953 9,457,154 and 10,335,462
|
|
Cite Document
2012 Exhibit: EX2012 Waiver of Service of Summons for Dr Reddy’s Laboratories, ...
Document
IPR2024-00009, No. 2012 Exhibit - EX2012 Waiver of Service of Summons for Dr Reddy’s Laboratories, Inc, Novo Nordisk Inc v Dr Reddy’s Lab’ys Ltd, No 122 cv 00298 CFC, Dkt 6 D Del, Mar 4,...
|
|
Cite Document
2002 Exhibit: EX2002 Petition for Inter Partes Review, Mylan Pharms Inc v Novo No...
Document
IPR2024-00009, No. 2002 Exhibit - EX2002 Petition for Inter Partes Review, Mylan Pharms Inc v Novo Nordisk AS, IPR2023 00724, Pap1 Mar 16, 2023 (P.T.A.B. Jan. 26, 2024)
|
|
Cite Document
